More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$706959954
EPS
-10.19
P/E ratio
--
Price to sales
1.03
Dividend yield
--
Beta
1.088611
Previous close
$15.46
Today's open
$15.48
Day's range
$15.17 - $15.61
52 week range
$9.30 - $16.63
show more
CEO
Michael C. Greiner
Employees
2227
Headquarters
Alpharetta, GA
Exchange
New York Stock Exchange
Shares outstanding
46418907
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Avanos Medical, Inc. (AVNS) Q4 2025 Earnings Call Transcript
Avanos Medical, Inc. (AVNS) Q4 2025 Earnings Call Transcript
Seeking Alpha • 7 hours ago

Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2025 Results
Exceeded full-year revenue and achieved the top end of full-year earnings-per-share guidance Delivered full-year organic growth of 6% in strategic segments Expanded transformation initiatives expected to deliver $15 to $20 million of incremental annualized savings by the end of 2026 ALPHARETTA, Ga., Feb. 24, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2025 results.
PRNewsWire • 12 hours ago

Avanos Medical (AVNS) Q4 Earnings and Revenues Surpass Estimates
Avanos Medical (AVNS) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.43 per share a year ago.
Zacks Investment Research • 8 hours ago

Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results
ALPHARETTA, Ga., Feb. 16, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2025 on Tues.
PRNewsWire • Feb 16, 2026

CMS Maintains NOPAIN Act Eligibility for ON‑Q* and AmbIT* Infusion Pumps; Adds Game Ready* in 2026
ALPHARETTA, Ga., Feb. 3, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) announced today that the Centers for Medicare and Medicaid Services (CMS) has released the 2026 Medicare Hospital Outpatient Prospective Payment System (OPPS) and Medicare Ambulatory Surgical Center (ASC) Payment System Final Rule.
PRNewsWire • Feb 3, 2026

Reasons to Retain Avanos Medical Stock in Your Portfolio Now
AVNS shows solid 3Q25 momentum from SNS and PMR growth, aided by M&A and cost cuts, even as tariffs and FX volatility linger.
Zacks Investment Research • Jan 29, 2026

AVNS & Siemens Healthineers Team Up on Advanced Integrated Pain Care
Avanos Medical teams up with an imaging partner to pair RFA with mobile imaging, targeting the shift of complex pain procedures to outpatient care.
Zacks Investment Research • Jan 26, 2026

Avanos Medical and Siemens Healthineers Collaborate to Advance Integrated Solutions for Outpatient and Interventional Pain Management
ALPHARETTA, Ga., Jan. 20, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) and Siemens Healthineers today announced a strategic co-marketing agreement to advance outpatient and interventional pain care through an integrated ecosystem of imaging and radiofrequency ablation (RFA) technologies.
PRNewsWire • Jan 20, 2026

Avanos Medical, Inc. (AVNS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Avanos Medical, Inc. (AVNS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Seeking Alpha • Jan 14, 2026

Avanos Medical, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
ALPHARETTA, Ga., Jan. 7, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Pacitti, chief executive officer, will present at the 44th Annual J.P.
PRNewsWire • Jan 8, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Avanos Medical Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.